If you're on an MS disease-modifying therapy and you're concerned about how effective your COVID-19 vaccination might be, or you aren't sure whether having MS qualifies you as being immunocompromised and cleared to receive a third dose of the COVID-19 vaccine, or you can't begin to figure out whether you qualify to receive a COVID-19 booster, then this podcast episode is for you.
Joining me to help us make sense of the flurry of recent announcements by the CDC and provide us with an update on his lab's work in looking at the immune response to COVID-19 vaccines among people living with MS who are on b-cell depleting therapies is the Chief of the Division of Multiple Sclerosis and Related Disorders and the Director of the Center for Neuroinflammation and Experimental Therapeutics at the University of Pennsylvania, Dr. Amit Bar-Or.
If you're living with MS in the U.K., we'll update you on your eligibility to receive a COVID-19 booster.
If you're living with MS in the European Union, we'll update you on the EMA's recommendation of Vumerity, an oral disease-modifying therapy for adults with relapsing-remitting MS.
We'll tell you about a drug that's been on the market for over a decade that's been shown to help manage overactive bladder among people living with MS.
Imagine having your phone send you an email or text letting you know that you're showing early signs of depression or cognitive dysfunction. We're talking about potentially game-changing technology that Apple is developing for the iPhone.
And we'll share the details of Episode 3 of The MS Caregiver Conundrum, which debuts Thursday, September 30th. Parenting includes its own set of caregiving responsibilities. Imagine adding the additional responsibilities that go with caring for a child with MS. In Episode 3, of The MS Caregiver Conundrum, we'll meet two remarkable moms, each of whom is not only a parent but a caregiver for a child living with pediatric MS.
We have a lot to talk about! Are you ready for RealTalk MS??!
Vaccine booster shots for people with MS in the U.K. 2:04
Vumerity for people with MS in the European Union? 3:48
Drug helps treat overactive bladder among people with MS 4:30
Apple is developing tech to identify depression and cognitive decline 6:11
Dr. Amit Bar-Or updates us on who gets a COVID-19 vaccine booster, who gets a 3rd dose, and all the rest 8:37
Share this episode 26:50
Catch The MS Caregiver Conundrum 27:10
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/213
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
National MS Society COVID-19 Vaccine Guidance for People Living with MS
National MS Society Additional (3rd) COVID-19 Vaccine Dose Guidance for People Living with MS
The MS Caregiver Conundrum Podcast
STUDY: Efficacy of Fesoterodine Fumarate (8 mg) in Neurogenic Detrusor Overactivity Due to Spinal Cord Lesion or Multiple Sclerosis: A Prospective Study
Register for Big October 2021
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS
Download the RealTalk MS App for Android
Give RealTalk MS a rating and review
RealTalk MS Episode 213
Guest: Dr. Amit Bar-Or
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS